Cannabis Bioscience International Holdings (CBIH) Stock Analysis & Winston Score

Cannabis Bioscience International Holdings is a small healthcare company focused on developing cannabis-based medicines and treatments. It works on specialty pharmaceutical products that use compounds found in the cannabis plant, targeting patients who need alternative medical therapies. The company operates in the specialty and generic drug manufacturing industry, which is heavily regulated by government agencies.

The company earns revenue by developing and selling its pharmaceutical products, though its financials show it is currently spending far more than it earns, with a deeply negative operating margin. It is a very small company, with a market cap near zero, and operates primarily in the United States. The main risk is straightforward: the company is burning through cash, has almost no gross profit, and faces intense regulatory hurdles around cannabis-derived drugs, meaning it must either raise more money or reach profitability before its resources run out.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-25.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+100.0% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

58.4%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$90 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

Cannabis Bioscience International Holdings has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

-364.1%

Thin — -364.1% gross margin

Operating Margin

-832.3%

Losing money on operations — -832.3%

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-45.7%

Shrinking sales (-45.7% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-317.6%

Burning cash (-317.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial